Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
China Suspends GSK Tender Qualification Under Dutasteride Ban
Nov 03 2022
•
By
Brian Yang
GSK GETS CHINA BLACKLISTED FOR PUBLIC TENDER DUE TO DUTASTERIDE BAN • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from China
More from Focus On Asia